Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesA Phase IB Trial of Intravenous INO-1001 Plus Oral Temozolomide in Subjects with Unresectable Stage-III or IV Melanoma
Cancer Investigation, 07/29/09
Bedikian AY et al. – INO–1001 at doses of 100, 200 and 400 mg was given intravenous for 1 hr q 12 hr for 10 doses. INO–1001 had a moderate clearance, volume of distribution and a relatively short terminal half–life. Myelosuppression and elevation of liver transaminases were dose–limiting toxicities (DLTs) of INO–1001 at 400 mg.
Related Articles
A Phase II Study of Cisplatin and Temozolomide in Heavily Pre-treated Patients with Temozolomide-refractory High-grade Malignant Glioma
Anticancer Research, 11/13/09
Relevance Score: 89%
Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status
Journal of Neuro-Oncology, 10/27/09
Relevance Score: 87%
Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme
Expert Review of Anticancer Therapy, 11/12/09
Relevance Score: 84%
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
Journal of Clinical Oncology, 11/12/09
Relevance Score: 84%
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma
Neuro-Oncology, 10/06/09
Relevance Score: 84%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Homoeopathic versus Conventional Therapy for Atopic Eczema in Children: Medical and Economic Results
Dermatology, 12/04/09
Non-psoriatic dermatologic uses of monoclonal antibody therapy
Journal of Dermatological Treatment , 12/04/09
Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: A randomized clinical study
Journal of Dermatological Treatment , 12/04/09
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma
Medical Oncology, 12/04/09
Cutaneous lymphangioma circumscriptum: frog spawn on the skin
International Journal of Dermatology, 12/03/09
Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
Cancer Epidemiology, 12/03/09
Sponsor
Article Search
Sponsor